Comparison Chart Lineage Cell Therapeutics, Inc.

Equities

LCTX

US53566P1093

Market Closed - Nyse 16:00:00 2024-05-31 EDT 5-day change 1st Jan Change
1 USD +1.13% Intraday chart for Lineage Cell Therapeutics, Inc. -4.76% -8.26%
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
LINEAGE CELL THERAPEUTICS, INC.+1.13%-4.76%-8.26%-20.63%+1.01% 189M
Bearish
Neutral
Neutral

Technical Rankings Surperformance